Abstract:Rat liver 3 alpha-hydroxysteroid dehydrogenase (3 alpha-HSD, EC 1.1.1.50) inactivates circulating androgens, progestins, and glucocorticoids. 3 alpha-HSD is a member of the aldo-keto reductase superfamily, and the X-ray structure of the apoenzyme shows the presence of an (alpha/beta)8 barrel [Hoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M., & Lewis, M. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 2517-2521]. As yet, a three-dimensional structure of the ternary complex E.NADPH.steroid is unavailable. To identify regions of the enzyme involved in steroid hormone recognition, we have employed mechanism-based inactivators and site-directed mutagenesis. (3 RS)-1,10-Seco-5 alpha-estr-1-yne-3,17 beta-diol (1) and (17 RS)- 17-hydroxy-14,15-secoandrost-4-en-15-yn-3-one (3) are secosteroids which contain latent Michael acceptors (alpha,beta-unsaturated alcohols) at opposite ends of the steroid nucleus (at the C-3 and C-17 positions, respectively). It was found that compounds 1 and 3 inactivated 3 alpha-HSD only in the presence of NAD+. The requirement for cofactor implies that 1 and 3 are oxidized to the corresponding alpha,beta-unsaturated ketones for inactivation to occur. Chemically prepared 17 beta-hydroxy-1,10-seco-5 alpha-estr-1-yn-3-one (2) and 14,15-secoandrost-4-en-15-yne-3,17-dione (4), the presumed products of 1 and 3 oxidation, behaved as stoichiometric inactivators of 3 alpha-HSD. In the presence and absence of NAD+, 2 and 4 inactivated > 50% of the enzyme in 10 s or less.(ABSTRACT TRUNCATED AT 250 WORDS)

SYNTHESIS OF (17R) AND (17S)-17-HYDROXY-14,15-SECOANDROST-4-EN-16-YN-3-ONE AND THE X-RAY CRYSTAL-STRUCTURE OF THE (17S)-DIASTEREOMER

Synthesis of (17R)- and (17S)-17-hydroxy-14, 15-secoandrost-4-en-15-yn-3-one and the X-ray crystal structure of the (17S)-diastereomer

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

Synthesis of 1,10-Seco-5α-estr-1 -Ynes: Potential Mechanism-Based Inhibitors of 3Α- and 3Β-Hydroxysteroid Dehydrogenases

Synthesis of 1,10-seco-5?-estr-1 -ynes: potential mechanism-based inhibitors of 3?- and 3?-hydroxysteroid dehydrogenases

A Highly Stereoselective Synthesis of C-24 and C-25 Oxysterols from Desmosterol.

Synthesis and Configuration of the Nonadecenetriol Isolated from Seeds of Persea Americana

Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors

Synthesis and Configuration of the Phenolic Nonadecanediol Isolated from the Resinous Exudates of Heliotropium Sinuatum

Synthesis of (5Α)-17-azaandrostan-3-ols and (5Α)-17-aza-d-homoandrostan-3-ols and Their N-acylated Derivatives

Stereoselective Synthesis of the Two Trans-(16-hydroxymethyl)-3-methoxy-13α-estra-1,3,5(10)-trien-17-ol Isomers

Stereoselective synthesis of the two major metabolites of spironolactone, 3alpha- and 3beta-hydroxy-7alpha-methylthio-17alpha-pregn-4-ene-21,17-carbolactone.

Synthesis of 13β- and 13α-epimers of 3-hydroxy-17-hydroxymethylestra-1,3,5(10)-triene and considerations on their hormonal and antiproliferative potency

Derivatives of 16alpha-hydroxy-dehydroepiandrosterone with an additional 7-oxo or 7-hydroxy substituent: synthesis and gas chromatography/mass spectrometry analysis

Synthesis of Two Stereoisomers of Potentially Bioactive 13,19,20-Trihydroxy Derivative of Docosahexaenoic Acid

Biocatalytic Steroidal 9α‐Hydroxylation and Fragmentation Enable the Concise Chemoenzymatic Synthesis of 9,10‐Secosteroids

An Efficient Synthesis of 5Α-Androst-1-ene-3,17-dione

Secosteroid Mechanism-Based Inactivators and Site-Directed Mutagenesis As Probes for Steroid Hormone Recognition by 3.Alpha.-Hydroxysteroid Dehydrogenase

Modulating the active site lid of an alcohol dehydrogenase from Ralstonia sp. enabled efficient stereospecific synthesis of 17β-hydroxysteroids

Syntheses of Some 17-Heterocyclic Substituted Androstene Derivatives as Inhibitors of Human 17α-Hydroxylase/C17,20-layse(P45017α)

Synthesis of novel D-ring fused 7'-aryl-androstano[17,16-d][1,2,4] triazolo[1,5-a]pyrimidines.